Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001213900-24-078633

Director acquired 275,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fairmount Funds Management LLC · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-09-11 Grant or award : show line 1 in the form +275,000 $23.00 $6,325,000 638,614 I

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-09-11 Grant or award : show line 2 in the form Series A Non-Voting Convertible Preferred Stock +160 $23,000.00 $3,680,000 160 I
Loading xslF345X05/ownership.xml…